On Friday, Shares of Transocean Ltd. (NYSE:RIG), lost -0.10% to $20.79.
Transocean, declared that the company`s shareholders approved at the 2015 Annual General Meeting a U.S. dollar-denominated dividend of $0.60 per share, or about $218 million in the aggregate (based upon the number of presently outstanding shares), out of additional paid-in capital. The Board anticipates that the dividend will be payable in four quarterly installments set for June 2015, September 2015, December 2015, and March 2016.
In addition, shareholders elected all director and compensation committee nominees, and elected Merrill A. “Pete” Miller, Jr. as Chairman of the Board of Directors.
Transocean Ltd., together with its auxiliaries, provides offshore contract drilling services for oil and gas wells worldwide. The company primarily offers deepwater and harsh environment drilling services. As of February 17, 2015, it owned or had partial ownership interests in, and operated 71 mobile offshore drilling units that comprise of 44 high-specification floaters, 17 midwater floaters, and 10 high-specification jackups.
Shares of The Dow Chemical Company (NYSE:DOW), inclined 0.53% to $51.51, during its last trading session.
The Dow Chemical Company, has declared a dividend of 42 cents per share, payable July 30, 2015, to shareholders of record on June 30, 2015.
This marks the 415th successive cash dividend issued by the Company. Dow has paid its shareholders cash dividends every quarter since 1912.
The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments.
At the end of Friday’s trade, Shares of St. Jude Medical Inc. (NYSE:STJ), gained 0.63% to $74.96.
St. Jude Medical, declared important new data presented during the Heart Rhythm Society’s (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the administration of Class III heart failure patients.
A presentation during HRS 2015 comprised of Pulmonary Artery Pressure Administration in Heart Failure Patients with Cardiac Resynchronization Therapy or Implantable Cardioverter Defibrillator Devices Significantly Reduces Hospitalizations and Mortality Above and Beyond Background Guideline-Directed Medical Therapy. These data were presented by Dr. William T. Abraham, co-primary investigator of the landmark CHAMPION clinical trial, which supported FDA approval of the CardioMEMS HF System.
St. Jude Medical, Inc., together with its auxiliaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm administration, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies.
Finally, SINA Corporation (NASDAQ:SINA), ended its last trade with 1.76% gain, and closed at $43.46.
SINA Corporation, declared its unaudited financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Highlights
- Net revenues raised 8% year over year to $184.6 million. Non-GAAP net revenues raised 9% year over year to $182 million.
- Advertising revenues grew 11% year over year to $150.4 million. Non-advertising revenues were $34.2 million. Non-GAAP non-advertising revenues were $31.6 million.
- Net loss attributable to SINA was $10.3 million, or $0.18 diluted net loss per share attributable to SINA. Non-GAAP net income attributable to SINA was $3 million, or $0.04 non-GAAP diluted net income per share attributable to SINA.
SINA Corporation, through its auxiliaries, operates as an online media company in the People’s Republic of China. It operates SINA.com, an online brand advertising portal that provides region-focused format and content, counting multimedia news; sporting events news; automobile-related news; business news coverage and personal finance columns; entertainment news and events; technology updates; interactive video products, such as news, sports, entertainment, and education; and education, digital, fashion, eLadies, luxury, health, collectibles, travel, and other interest-based channels.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
